Vir Biotechnology, Inc.

Biopharmaceutical

About Vir Biotechnology, Inc.

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing medicines for serious infectious diseases and cancer by powering the immune system. The company's clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications, along with a preclinical portfolio spanning infectious diseases and oncologic malignancies. Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease applications.

Work at Vir Biotechnology, Inc.?

Post a role here — reach candidates already searching for your company.

Open Positions at Vir Biotechnology, Inc. (1)

Senior Regulatory Writer (Temporary)

Vir Biotechnology, Inc.

Full-time

RemoteUSD 130 - 170Today

Hiring Intelligence

Beta · Sourced from candidate reports

Be the first to share your experience with Vir Biotechnology, Inc..

Your reply helps other candidates know what to expect.